Trellus Health Statistics

Total Valuation

Trellus Health has a market cap or net worth of GBP 2.66 million. The enterprise value is -3.70 million.

Market Cap	2.66M
Enterprise Value	-3.70M

Important Dates

The last earnings date was Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Trellus Health has 161.51 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	161.51M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	18.18%
Owned by Institutions (%)	63.37%
Float	73.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	61.23
PB Ratio	0.22
P/TBV Ratio	0.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.70
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.14

Current Ratio	14.14
Quick Ratio	14.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -35.08% and return on invested capital (ROIC) is -23.39%.

Return on Equity (ROE)	-35.08%
Return on Assets (ROA)	-22.76%
Return on Invested Capital (ROIC)	-23.39%
Return on Capital Employed (ROCE)	-45.53%
Revenue Per Employee	1,404
Profits Per Employee	-170,072
Employee Count	31
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.44% in the last 52 weeks. The beta is 2.37, so Trellus Health's price volatility has been higher than the market average.

Beta (5Y)	2.37
52-Week Price Change	-28.44%
50-Day Moving Average	1.92
200-Day Moving Average	1.37
Relative Strength Index (RSI)	35.59
Average Volume (20 Days)	690,653

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Trellus Health had revenue of GBP 43,520 and -5.27 million in losses. Loss per share was -0.03.

Revenue	43,520
Gross Profit	43,520
Operating Income	-5.62M
Pretax Income	-5.27M
Net Income	-5.27M
EBITDA	-5.57M
EBIT	-5.62M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 6.37 million in cash and n/a in debt, giving a net cash position of 6.37 million or 0.04 per share.

Cash & Cash Equivalents	6.37M
Total Debt	n/a
Net Cash	6.37M
Net Cash Per Share	0.04
Equity (Book Value)	12.35M
Book Value Per Share	0.08
Working Capital	6.06M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.63M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-12,923.59%
Pretax Margin	-12,114.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Trellus Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-197.84%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Trellus Health has an Altman Z-Score of 5.61.

Altman Z-Score	5.61
Piotroski F-Score	n/a